Searched for
MEXILETINE
Pharma market in good health; lifestyle diseases may be risingThe other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the...- Senores Pharma shares list at 53% premium over IPO priceSenores Pharmaceuticals’ shares debuted with over a 50% premium on Indian exchanges, reflecting a robust investor response to the IPO, whic...
- Senores Pharmaceuticals IPO: Check allotment status, GMP, listing date and other detailsSenores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's we...
- Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key detailsSenores Pharma's IPO subscription was oversubscribed at 93.41 times driven by retail, non-institutional, and qualified institutional buyers...
- Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price bandRetail investors subscribed to the issue 38.34 times, while non-institutional investors (NIIs) subscribed 24.48 times. Qualified institutio...
- Senores Pharma IPO subscribed 1.8 times on Day 1: Check key dates, price band, GMP and reviewSenores Pharmaceuticals' IPO received 1.8 times subscription on its opening day, driven primarily by retail investors, who oversubscribed b...
- Lupin enters pact with Medis to distribute orphan drug in EuropeNDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following vol...
- Lupin gets European Commission nod for myotonia treatment drugLupin said it is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter o...
Load More